Literature DB >> 8982352

Induction of antibodies against human prion proteins (PrP) by DNA-mediated immunization of PrP0/0 mice.

S Krasemann1, M Groschup, G Hunsmann, W Bodemer.   

Abstract

Prion diseases are neurodegenerative disorders, affecting humans and animals. The human diseases include kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and fatal familial insomnia (FFI). To generate monospecific antisera against human prion proteins we have immunized mice with DNA coding for different human prion proteins. We constructed immunization vectors expressing individual genotypes of either the cellular prion gene (PRNP) or mutant forms under appropriate promoters. This approach avoids the preparation of infectious material for immunization. To circumvent immunological tolerance prion protein-deficient PrP0/0 mice were used for the DNA-mediated immunization. Thereby monospecific sera were raised capable of specifically precipitating in vitro synthesized human prion proteins. With prion protein-specific peptide ELISAs, we found that antibodies are predominantly directed against the octapeptide repeat region and to a lesser extent to regions comprising the signal peptide, the neurotoxic domain or the GPI anchor. In contrast, prion gene-positive (PrP+/+) BALB/c mice immunized under the same experimental conditions as the PrP0/0 mice did not respond with antibody formation against the human prion protein. This is the first report clearly showing that immune competent prion protein-deficient mice react with a vigorous polyclonal immune response after DNA-mediated immunization with human prion gene sequences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982352     DOI: 10.1016/s0022-1759(96)00165-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  19 in total

1.  PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.

Authors:  Sophie Paquet; Nathalie Daude; Marie-Pierre Courageot; Jérôme Chapuis; Hubert Laude; Didier Vilette
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 2.  Genetic vaccines: strategies for optimization.

Authors:  G Gregoriadis
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

3.  A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP.

Authors:  Carola Munoz-Montesino; Djabir Larkem; Clément Barbereau; Angélique Igel-Egalon; Sandrine Truchet; Eric Jacquet; Naïma Nhiri; Mohammed Moudjou; Christina Sizun; Human Rezaei; Vincent Béringue; Michel Dron
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

4.  Separation of native prion protein (PrP) glycoforms by copper-binding using immobilized metal affinity chromatography (IMAC).

Authors:  Henrik Müller; Alexander Strom; Gerhard Hunsmann; Andreas W Stuke
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

5.  Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor.

Authors:  Etienne Morel; Thibault Andrieu; Fabrice Casagrande; Sabine Gauczynski; Stefan Weiss; Jacques Grassi; Monique Rousset; Dominique Dormont; Jean Chambaz
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

6.  Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC.

Authors:  Sandra Müller; Roland Kehm; Michaela Handermann; Nurith J Jakob; Udo Bahr; Björn Schröder; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

7.  Prion infection of epithelial Rov cells is a polarized event.

Authors:  Sophie Paquet; Elifsu Sabuncu; Jean-Louis Delaunay; Hubert Laude; Didier Vilette
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.

Authors:  Véronique Perrier; Jérôme Solassol; Carole Crozet; Yveline Frobert; Chantal Mourton-Gilles; Jacques Grassi; Sylvain Lehmann
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

9.  Generation of polyclonal rabbit antisera to mouse melanoma associated antigens using gene gun immunization.

Authors:  D R Surman; K R Irvine; E P Shulman; T M Allweis; S A Rosenberg; N P Restifo
Journal:  J Immunol Methods       Date:  1998-05-01       Impact factor: 2.303

10.  Generating Bona Fide Mammalian Prions with Internal Deletions.

Authors:  Carola Munoz-Montesino; Christina Sizun; Mohammed Moudjou; Laetitia Herzog; Fabienne Reine; Jérôme Chapuis; Danica Ciric; Angelique Igel-Egalon; Hubert Laude; Vincent Béringue; Human Rezaei; Michel Dron
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.